Tkanka tłuszczowa – udział w patogenezie nadciśnienia tętniczego i chorób nerek

• Authors: Adamczak Marcin , Bartmańska Magdalena , Więcek Andrzej
• Languages of publication: PL

Keywords

PL

adiponektyna; leptyna; nadciśnienie tętnicze; przewlekła choroba nerek; tkanka tłuszczowa

• Publisher: Stowarzyszenie Przyjaciół Medycyny Rodzinnej i Lekarzy Rodzinnych
• Journal: Family Medicine & Primary Care Review
• Year: 2013
• Issue: 2
• Pages: 213-215

Contributors

author

Adamczak Marcin

author

Bartmańska Magdalena

author

Więcek Andrzej

References

• Adamczak M, Więcek A. The adipose tissue as an endocrine organ. Semin Nephrol 2013; 33(1): 2–13.
• Adamczak M, Słabiak-Błaż N, Więcek A. Hipoadiponektynemia – znaczenie w patogenezie nadciśnienia tętniczego. Nadciśn Tętn 2010; 1: 83–92.
• Kadowski T, Yamauchi T. Adiponectin and adiponectin receptors. Endocr Rev 2005; 26: 439–451.
• Adamczak M, Chudek J, Więcek A. Adiponectin in patients with chronic kidney disease. Seminar Dial 2009; 22: 391–395.
• Chow WS, Cheung BM, Tso AW, et al. Hypoadiponectinemia as a predictor for the development of hypertension: a 5-year prospective study. Hypertension 2007; 49(6): 1455–1461
• Tanida M, Shen J, Horii Y, et al. Effects of adiponectin on the renal sympathetic nerve activity and blood pressure in rats. Exp Biol Med (Maywood) 2007; 232(3): 390–397.
• Ouchi N, Ohishi M, Kihara S, et al. Association of hypoadiponectinemia with impaired vasoreactivity. Hypertension 2003;42(3): 231–234.
• Ignacy W, Chudek J, Adamczak M, et al. Reciprocal association of plasma adiponectin and serum C-reactive protein concentration in haemodialysis patients with end-stage kidney disease-a follow-up study. Nephron Clin Pract 2005; 101(1): c18–c24.
• Zoccali C, Mallamaci F, Tripepi G, et al. Adiponectin, metabolic risk factors, and cardiovascular events among patients with end-stage renal disease. J Am Soc Nephrol 2002; 13: 134–141.
• Adamczak M, Szotowska M, Chudek J, et al. Plasma adiponectin concentration before and after successful kidney transplantation.Transplant Proc 2003; 35: 2186–2189.
• Becker B, Kronenberg F, Kielstein JT , et al. Renal insulin resistance syndrome, adiponectin and cardiovascular events in patients with kidney disease: the mild and moderate kidney disease study. J Am Soc Nephrol 2005; 16: 1091–1098.
• Menon V, Li L, Wang X, et al. Adiponectin and mortality in patients with chronic kidney disease. J Am Soc Nephrol 2006; 17:2599–2606.
• Drechsler C, Krane V, Winkler K, et al. Changes in adiponectin and the risk of sudden death, stroke, myocardial infarction, and mortality in hemodialysis patients. Kidney Int 2009; 76(5): 567–575.
• Tsigalou C, Chalikias G, Kantartzi K, et al. Differential effect of baseline adiponectin on all-cause mortality in hemodialysis patients depending on initial body mass index. Long-term follow-up data of 4.5 years. J Ren Nutr 2013; 23(1): 45–56.
• Auwerx J, Staels B. Leptin. Lancet 1998; 351(9104): 737–742.
• Friedman JM, Halaas JL . Leptin and the regulation of body weight in mammals. Nature 1998; 395(6704): 763–770.
• Dunbar JC , Hu Y, Lu H. Intracerebroventricular leptin increases lumbar and renal sympathetic nerve activity and blood pressure in normal rats. Diabetes 1997; 46(12): 2040–2043.
• Aizawa-Abe M, Ogawa Y, Masuzaki H, et al. Pathophysiological role of leptin in obesity-related hypertension. J Clin Invest 2000; 105(9): 1243–1252.
• Ozata M, Ozdemir IC , Licinio J. Human leptin deficiency caused by a missense mutation: multiple endocrine defects, decreased sympathetic tone, and immune system dysfunction indicate new targets for leptin action, greater central than peripheral resistance to the effects of leptin, and spontaneous correction of leptin-mediated defects. J Clin Endocrinol Metab 1999;84(10): 3686–3695.
• Kramer CK , von Mühlen D, Barrett-Connor E. Does leptin predict incident hypertension in older adults? Clin Endocrinol (Oxf)2010; 73(2): 201–205.
• Maenhaut N, Van de Voorde J. Regulation of vascular tone by adipocytes. BMC Med 2011; 9: 25.
• Wolf G, Hamann A, Han DC , et al. Leptin stimulates proliferation and TG F-beta expression in renal glomerular endothelial cells: potential role in glomerulosclerosis. Kidney Int 1999; 56: 860–872.
• Frederich RC , Hamann A, Anderson S, et al. Leptin levels reflect body lipid content in mice: evidence for diet-induced resistance to leptin action. Nat Med 1995; 1(12): 1311–1314.
• Tesauro M, Mascali A, Franzese O, et al. Chronic kidney disease, obesity, and hypertension: the role of leptin and adiponectin.Int J Hypertens 2012; 2012: 943605.
• Wolf G, Chen S, Han D, Ziyadeh F. Leptin and renal disease. Am J Kidney Dis 2002; 39(1): 1–11.
• Martin S, Qasim A, Reilly M. Leptin resistance: a possible interface of inflammation and metabolism in obesity-related cardiovascular disease. J Am Coll Cardiol 2008; 52(15): 1201–1210.